Health

Health · UK

NICE backs life-extending Enhertu for HER2-low advanced breast cancer on the NHS

Around 1,000 people with HER2-low advanced breast cancer in England can now be offered Enhertu. It was the only breast cancer drug NICE had been unable to recommend since 2018.

By The Newsroom · Verified · Source: NICE (National Institute for Health and Care Excellence)

The numbers